We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(Reuters) Apr 29, 2013 - Incyte Corporation announced today that it has earned a $25.0 million milestone payment from Novartis based on the formal initiation of a Phase II clinical trial evaluating c-MET inhibitor INC280 (formerly INCB28060) as monotherapy in patients with advanced hepatocellular carcinoma.
read article 
(Yahoo! Finance) Apr 29, 2013 - Peregrine Pharmaceuticals today announced the completion of patient enrollment in an investigator-sponsored Phase I trial evaluating bavituximab in combination with the chemotherapeutic agent paclitaxel in patients with metastatic HER2-negative breast cancer.
read article 
(Karolinska Institutet) Apr 29, 2013 - For the first time, researchers at Karolinska Institutet have managed to obtain detailed images of the way in which the transport protein GLUT transports sugars into cells.
read press release 
(R&D Magazine) Apr 29, 2013 - A team of student researchers and their professors from 20 laboratories around the country have gotten a new view of cancer cells.
read article 
(Reuters Health) Apr 26, 2013 - Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease.
read article 
(Xconomy Boston) Apr 29, 2013 - Forma Therapeutics is entering into a different kind of deal with Celgene that could turn the Watertown, MA-based company into a bigger enterprise that discovers, develops, to someday market its own drugs.
read article 
(New York Times) Apr 27, 2013 - Cancers have long been categorized by the tissue where they originate in the body, but new tools and tests are helping doctors tailor treatment to specific gene mutations.
read article 
(ASH) Apr 25, 2013 - The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to an article published online in Blood, the Journal of the American Society of Hematology (ASH).
read press release 
(Los Angeles Times) Apr 25, 2013 - Federal researchers shut down a clinical trial of an HIV vaccine involving about 2,500 subjects after it is found to be ineffective at preventing healthy subjects from contracting the virus.
read article (free registration required) 
(Wall Street Journal) Apr 25, 2013 - The health-care sector, one of the last redoubts of stable and well-paying jobs for less-educated workers, is beginning to look less secure.
read article (paid subscription required) 
(CNN Money) Apr 26, 2013 - A growing number of Americans are skipping needed medical care because they can't afford it.
read article 
(Reuters) Apr 25, 2013 - European regulators declined to approve marketing of Pfizer Inc's new rheumatoid arthritis treatment Xeljanz, citing the risks of the drug compared with its potential benefit, the company said on Thursday.
read article 
(Reuters) Apr 26, 2013 - The Food and Drug Administration would gain greater authority over pharmacies that compound sterile drugs for tailored use and ship them across state lines, under proposed legislation announced on Friday.
read article 
(BBC News) Apr 25, 2013 - Cancer is threatening to overwhelm Latin American countries, experts writing in Lancet Oncology warn.
read article 
(Yahoo! Finance) Apr 25, 2013 - Maine Center for Cancer Medicine and Blood Disorders (MCCM) has been nationally recognized for its commitment to continuous quality improvement in oncology care.
read article 
(The US Oncology Network) Apr 25, 2013 - CURE magazine announced the winner of the 2013 Extraordinary Healer Award for Oncology Nursing during a special award ceremony at the Oncology Nursing Society’s (ONS) 38th Annual Congress.
read corporate press release 
(Washington Times/Inside Politics blog) Apr 26, 2013 - An advocacy wing of the American Cancer Society said Friday that President Obama’s proposed cigarette tax hike would save the nation more than $63 billion in long-term health care costs.
read article 
(ASH) Apr 25, 2013 - Congress Working on Legislation to Reform Physician Payment; ASH Advocates for a Minimum of 5 Years of Congressionally Mandated Stable Payment; Representatives Higgins and King will Introduce Cancer Oral Drug Parity Legislation; ASH Advocates for Patients with Blood Cancers to Have Equal Access to Treatment; and more.
read article 
(CNN Money/Fortune) Apr 25, 2013 - As more employees choose to continue working after being diagnosed with cancer, employers must grapple with relatively new territory.
read article 
(MarketWatch) Apr 25, 2013 – Company to discontinue discovery research program and close research laboratory facility to focus resources on clinical development in hematologic malignancies.
read article 
(The Street) Apr 26, 2013 - Here are some highlights from the upcoming ASCO annual meeting based on my first, quick look through the abstracts:
read article 
(Yahoo! Finance) Apr 26, 2013 - Xencor announced today that MorphoSys AG has dosed the first patient in a Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia (B-ALL).
read article 
(Daily Mail) Apr 26, 2013 - Drinking two cups of coffee a day could stop breast cancer recurring in recovering patients, new research has revealed.
read article 
(Weill Cornell Medical College) Apr 25, 2013 - Sequencing of 57 prostate cancer genomes shows cancer gains powerful advantage with abrupt intervals of complex, large scale DNA reshuffling.
read press release 
(Reuters Health) Apr 25, 2013 - Terminally ill cancer patients who watched either of two videos about the option to forego resuscitation overwhelmingly elected that route for the patient in the video, if not for themselves, according to a new study.
read article 